These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1754816)

  • 1. Quantitative clinical assessment of disease activity in systemic lupus erythematosus: progress report and research agenda.
    Liang MH; Fortin PR; Isenberg DA; Snaith L
    Rheumatol Int; 1991; 11(3):133-6. PubMed ID: 1754816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
    Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
    J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
    Ward MM; Marx AS; Barry NN
    J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus.
    Liang MH; Socher SA; Larson MG; Schur PH
    Arthritis Rheum; 1989 Sep; 32(9):1107-18. PubMed ID: 2775320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation.
    Gladman DD; Goldsmith CH; Urowitz MB; Bacon P; Bombardier C; Isenberg D; Kalunian K; Liang MH; Maddison P; Nived O
    J Rheumatol; 1994 Aug; 21(8):1468-71. PubMed ID: 7983648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus.
    Gladman DD; Goldsmith CH; Urowitz MB; Bacon P; Bombardier C; Isenberg D; Kalunian K; Liang MH; Maddison P; Nived O
    J Rheumatol; 1992 Apr; 19(4):608-11. PubMed ID: 1593583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the clinical activity of systemic lupus erythematosus].
    Le Loët X
    Ann Med Interne (Paris); 1990; 141(3):261-4. PubMed ID: 2195948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus.
    Brunner HI; Feldman BM; Bombardier C; Silverman ED
    Arthritis Rheum; 1999 Jul; 42(7):1354-60. PubMed ID: 10403262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of lupus: where are we now?
    Hay E; Gordon C; Emery P
    Ann Rheum Dis; 1993 Mar; 52(3):169-72. PubMed ID: 8484667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
    Castrejón I; Tani C; Jolly M; Huang A; Mosca M
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical composite measures of disease activity and damage used to evaluate patients with systemic lupus erythematosus: A systematic literature review.
    Castrejón I; Rúa-Figueroa I; Rosario MP; Carmona L
    Reumatol Clin; 2014; 10(5):309-20. PubMed ID: 25022441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
    Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
    J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
    American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
    Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indicators of disease activity, prognosis, and treatment of systemic lupus erythematosus.
    Gladman DD
    Curr Opin Rheumatol; 1994 Sep; 6(5):487-92. PubMed ID: 7993706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of disease activity in Systemic Lupus Erythematosus: Lights and shadows.
    Ceccarelli F; Perricone C; Massaro L; Cipriano E; Alessandri C; Spinelli FR; Valesini G; Conti F
    Autoimmun Rev; 2015 Jul; 14(7):601-8. PubMed ID: 25742757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices.
    Griffiths B; Mosca M; Gordon C
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):685-708. PubMed ID: 16150398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms.
    Askanase AD; Castrejón I; Pincus T
    J Rheumatol; 2011 Jul; 38(7):1309-16. PubMed ID: 21459938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians.
    Chang E; Abrahamowicz M; Ferland D; Fortin PR;
    J Clin Epidemiol; 2002 May; 55(5):488-97. PubMed ID: 12007552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of the Levels of C4d-bearing Reticulocytes and High-avidity Anti-dsDNA Antibodies with Disease Activity in Systemic Lupus Erythematosus.
    Mora C; Medina-Rosas J; Santos AM; Jaimes DA; Arbeláez AM; Romero C; Cortes A; Londono J
    J Rheumatol; 2016 Sep; 43(9):1657-64. PubMed ID: 27134246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rating scale preference measure as an evaluative measure in systemic lupus erythematosus.
    Ward MM; Marx AS; Barry NN
    Lupus; 2000; 9(9):696-701. PubMed ID: 11199925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.